Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Actinium Pharmaceuticals, Inc. has filed 494 SEC EDGAR filings since 05 Feb 2007

SEC filing history

Showing 1-25 of 106 matching filings.

Per page
25
Current page
1
8-K File 001-36374

CURRENT REPORT

Filing date
29 May 2026
Reporting date
27 May 2026
Next action
Verify source filing
8-K/A File 001-36374

AMENDMENT NO.1 TO FORM 8-K

Filing date
26 Mar 2026
Reporting date
26 Nov 2025
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
13 Feb 2026
Reporting date
11 Feb 2026
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
26 Nov 2025
Reporting date
26 Nov 2025
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
09 May 2025
Reporting date
08 May 2025
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
27 Nov 2024
Reporting date
27 Nov 2024
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
05 Nov 2024
Reporting date
01 Nov 2024
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
05 Aug 2024
Reporting date
05 Aug 2024
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
01 Dec 2023
Reporting date
30 Nov 2023
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
10 Mar 2023
Reporting date
10 Mar 2023
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
21 Feb 2023
Reporting date
18 Feb 2023
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
30 Dec 2022
Reporting date
30 Dec 2022
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
09 Dec 2022
Reporting date
08 Dec 2022
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
31 Oct 2022
Reporting date
31 Oct 2022
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
29 Jun 2022
Reporting date
28 Jun 2022
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
13 Apr 2022
Reporting date
07 Apr 2022
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
09 Nov 2021
Reporting date
09 Nov 2021
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
23 Sep 2021
Reporting date
22 Sep 2021
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
20 Nov 2020
Reporting date
18 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
28 Oct 2020
Reporting date
28 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
14 Aug 2020
Reporting date
10 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

FORM 8-K

Filing date
05 Aug 2020
Reporting date
05 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
24 Jul 2020
Reporting date
22 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
19 Jun 2020
Reporting date
19 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
18 Jun 2020
Reporting date
16 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .